global-map

Resources

COVID-19 People's Vaccine

Why the HIV Community can make a difference
covid-19-people-vaccine

or many years the prohibitive prices of HIV medicines meant only the world’s wealthiest countries and people could afford them. While in the global north effective treatment was widely available from 1996 onwards, in low- and middle-income countries people continued to die in their millions. This is largely because pharmaceutical companies were unwilling to relinquish the monopolies granted to them under intellectual property rules to allow low-cost production of generic versions of their products.

  1. Download pdf